Establishing the Feasibility of Face Transplantation in Granulomatosis With Polyangiitis

@article{Hashem2016EstablishingTF,
  title={Establishing the Feasibility of Face Transplantation in Granulomatosis With Polyangiitis},
  author={Ahmed Mohamed Hashem and Gary S. Hoffman and Brian R Gastman and Steven L. Bernard and Risal S. Djohan and Mark F. Hendrickson and Graham S. Schwarz and Gaby D. Doumit and Bahar Bassiri Gharb and Antonio Rampazzo and James E. Zins and M. Siemionow and Frank Papay},
  journal={American Journal of Transplantation},
  year={2016},
  volume={16},
  pages={2213 - 2223}
}
Granulomatosis with polyangiitis (GPA; formerly Wegener's granulomatosis) is a rare vasculitis that commonly starts in the craniofacial region. We report a case that was masked by prior facial trauma and associated with pyoderma gangrenosum (PG). Disease progression and aggressive debridements led to severe facial tissue loss. The decision to perform a face transplant was controversial because of the risk of disease relapse on the facial allograft. We reviewed renal transplant outcomes in GPA… 
Face Transplantation for Granulomatosis With Polyangiitis (Wegener Granulomatosis): Technical Considerations, Immunological Aspects, and 3-Year Posttransplant Outcome
TLDR
This case represents a new underlying disease (trauma + GPA) leading to face transplantation and a unique clinical scenario where allografting was indicated for potentially life-threatening and sight-preserving reasons and not for mere functional and aesthetic concerns.
Successful reconstruction of an ocular defect resulting from granulomatosis with polyangiitis, following treatment with rituximab
Reporting Practices on Immunosuppression and Rejection Management in Face Transplantation: A Systematic Review.
TLDR
The current literature on face transplantation does not include consistent reporting on critical aspects of patient care, and medical protocols outlining guidelines for immunosuppression, graft surveillance, and management of rejection and graft failure are underreported.
The past the present and the future of face transplantation
  • M. Siemionow
  • Medicine
    Current opinion in organ transplantation
  • 2020
TLDR
For the future of face and other VCA, novel approaches of cell-based therapies or engineered scaffolds should be developed to make face transplantation safer.
Skeletal and Dental Outcomes after Facial Allotransplantation: The Cleveland Clinic Experience and Systematic Review of the Literature
TLDR
Skeletal and dental complications remain extremely common after facial allotransplantation involving either single- or double-jaw composites, and Corrective orthognathic surgery and dental extraction is often necessitated.
The decade of face transplant outcomes
  • M. Siemionow
  • Medicine
    Journal of Materials Science: Materials in Medicine
  • 2017
TLDR
Based on over 20 years of research experience in the field of vascularized composite allotransplantation (VCA), and clinical experience as a leading surgeon of the US first face transplantation, this review will summarize the well—known facts as well as unexpected outcomes and challenges of face transplants.
Outcomes After Tooth-Bearing Maxillomandibular Facial Transplantation: Insights and Lessons Learned.
First Lower Two-Thirds Osteomyocutaneous Facial Allograft Perfused by a Unilateral Facial Artery: Outcomes and Vascularization at 1 Year after Transplantation
TLDR
In this patient, a facial allograft comprising the lower two-thirds of the face including the maxilla and mandible is sufficiently perfused by one unilateral facial artery, however, bilateral venous outflow seems to be necessary.
The Second Helsinki Face Transplantation and the World Experience of Revision Surgery During the First Posttransplantation Year
TLDR
Surgical interventions are very common during the first postoperative year after FT, and composite FTs are more prone to complications necessitating surgical intervention than soft-tissue FTs.
...
1
2
...

References

SHOWING 1-10 OF 22 REFERENCES
Large Pyoderma Gangrenosum-Like Ulcers: A Rare Presentation of Granulomatosis with Polyangiitis
TLDR
A case of a previously healthy 52-year-old Caucasian man who presented with multiple progressively enlarging painful ulcers on his face, upper extremities, back, and abdomen over a two-month period, which revealed pyoderma gangrenosum-like features.
A case of granulomatosis with polyangiitis and pyoderma gangrenosum successfully treated with infliximab and rituximab
TLDR
A young male patient who was admitted with alveolar hemorrhage, arthritis and cutaneous lesions, who later developed bilateral orbital involvement and pyoderma gangrenosum (PG) is presented, who was refractory to conventional immunosuppressive therapy.
Renal Transplant in Wegener’s Granulomatosis Compared to Microscopic Polyangiitis
TLDR
Investigating how the underlying vasculitis diagnosis may influence outcomes following renal transplant at the Johns Hopkins Hospital between 1999 and 2008 concluded that patients with Wegener’s granulomatosis remained on hemodialysis longer (and may have had slightly worse renal outcomes following transplant) than patients with MPA.
Wegener granulomatosis: an analysis of 158 patients.
TLDR
The course of Wegener granulomatosis has been dramatically improved by daily treatment with cyclophosphamide and glucocorticoids, and has led to increasing concerns about toxicity resulting from prolonged cycloph phosphamide therapy and has encouraged investigation of other therapeutic regimens.
Wegener's granulomatosis presenting as pyoderma gangrenosum
TLDR
In this severe case of Wegener's granulomatosis prolonged methylprednisone and cyclophosphamide treatment was initiated and both the skin symptoms and thegranulomatosus infiltrations resolved.
The Dutch Transplantation in Vasculitis (DUTRAVAS) Study: Outcome of Renal Transplantation in Antineutrophil Cytoplasmic Antibody–associated Glomerulonephritis
TLDR
In this study in 110 Dutch patients, the recurrence rate of AAGN within 5 years after kidney transplantation appeared slightly higher than in previous reports, emphasizing the importance of clinical vigilance, because early treatment might be critical to rescuing the allograft.
Wegener's granulomatosis: patient-reported effects of disease on health, function, and income.
TLDR
Advances in medical care have transformed Wegener's granulomatosis from being a disease with a high potential for short-term mortality to being a chronic illness, and patients' assessments of the medical, socioeconomic, and quality of life effects of WG and its treatment are evaluated.
Substitution of Methotrexate for Cyclophosphamide in Wegener Granulomatosis: A 12-Year Single-Practice Experience
TLDR
In patients with WG, a strategy that limits or avoids CYC therapy produced a frequency of remission comparable to that achieved with conventional CYC protocols, excellent survival, and avoidance of long-term CYC toxicity.
The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand.
TLDR
Compared with ESRD patients without AAV, those with GPA have comparable renal replacement therapy outcomes, whereas MPA patients have comparable dialysis survival but poorer renal transplant allograft and patient survival rates.
Facial transplantation and immunosuppressed patients: a new frontier in reconstructive surgery.
TLDR
The rationale and IRB application process of this unique approach to this highly controversial procedure, which focuses on partial face transplantation on patients currently on immunosuppressants due to previous transplanted organ, and which patient population would risk less and overall benefit more from undergoingface transplantation are presented.
...
1
2
3
...